These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Are individuals with diabetes seeing better?: a long-term epidemiological perspective. Klein R; Klein BE Diabetes; 2010 Aug; 59(8):1853-60. PubMed ID: 20668290 [No Abstract] [Full Text] [Related]
6. Retinopathy risk: what is responsible? Hormones, hyperglycemia, or humalog? Response to Kitzmiller et al. Jovanovic L Diabetes Care; 1999 May; 22(5):846-8. PubMed ID: 10332693 [No Abstract] [Full Text] [Related]
10. Glucose control in the medical patient: bolus insulin dosing compared to basal-bolus insulin dosing. Deno KM; Schaper J Medsurg Nurs; 2011; 20(5):217-22, 234; quiz 223. PubMed ID: 22165780 [TBL] [Abstract][Full Text] [Related]
11. [Diabetic retinopathy and control of diabetes. II]. Kojima K; Suzuki M; Okajima T Nihon Ganka Kiyo; 1966 Apr; 17(4):509-17. PubMed ID: 6006518 [No Abstract] [Full Text] [Related]
12. Inpatient hyperglycemia: slide through the scale but cover the bases first. Asudani D; Calles-Escandon J J Hosp Med; 2007; 2 Suppl 1():23-32. PubMed ID: 17311238 [No Abstract] [Full Text] [Related]
13. American College of Endocrinology position statement on inpatient diabetes and metabolic control. Garber AJ; Moghissi ES; Bransome ED; Clark NG; Clement S; Cobin RH; Furnary AP; Hirsch IB; Levy P; Roberts R; Van den Berghe G; Zamudio V; Endocr Pract; 2004; 10(1):77-82. PubMed ID: 15251626 [No Abstract] [Full Text] [Related]
14. American College of Endocrinology position statement on inpatient diabetes and metabolic control. Garber AJ; Moghissi ES; Bransome ED; Clark NG; Clement S; Cobin RH; Furnary AP; Hirsch IB; Levy P; Roberts R; Van den Berghe G; Zamudio V; Endocr Pract; 2004; 10 Suppl 2():4-9. PubMed ID: 15251633 [No Abstract] [Full Text] [Related]
15. Glucose measurement: confounding issues in setting targets for inpatient management: response to Dungan et al. Mahoney J; Ellison J Diabetes Care; 2007 Jul; 30(7):e71; author reply e72. PubMed ID: 17596494 [No Abstract] [Full Text] [Related]
16. Retinopathy progression and visual outcomes after phacoemulsification in patients with diabetes mellitus. Mittra RA; Borrillo JL; Dev S; Mieler WF; Koenig SB Arch Ophthalmol; 2000 Jul; 118(7):912-7. PubMed ID: 10900103 [TBL] [Abstract][Full Text] [Related]
17. Retinopathy and visual impairment in diabetes, impaired glucose tolerance and normal glucose tolerance: the Nord-Trøndelag Health Study (the HUNT study). Sundling V; Platou CG; Jansson RW; Bertelsen G; Wøllo E; Gulbrandsen P Acta Ophthalmol; 2012 May; 90(3):237-43. PubMed ID: 20809910 [TBL] [Abstract][Full Text] [Related]
18. How to manage steroid diabetes in the patient with cancer. Oyer DS; Shah A; Bettenhausen S J Support Oncol; 2006 Oct; 4(9):479-83. PubMed ID: 17080737 [No Abstract] [Full Text] [Related]
19. Early insulinization to prevent diabetes progression. Raz I; Mosenzon O Diabetes Care; 2013 Aug; 36 Suppl 2(Suppl 2):S190-7. PubMed ID: 23882045 [No Abstract] [Full Text] [Related]
20. Inpatient management of diabetes and hyperglycemia. Bogun M; Inzucchi SE Clin Ther; 2013 May; 35(5):724-33. PubMed ID: 23688537 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]